# Astellas Pharma Inc. - Inspection Records

Source: https://www.keypedia.com/companies/astellas-pharma-inc/9a5bc049-426d-4313-b8b8-1ce28d48fa42

> Inspection records and compliance data for Astellas Pharma Inc. in Toyama, None. Access full analysis and detailed observations.

---

## Details

- Name: Astellas Pharma Inc.
- FEI Number: 3002807003
- City: Toyama
- State: None
- Country Name: Japan
- Address Line 1: 2-178, Kojin-Machi
- Zip Code: None

## Related Documents

- [FDA Inspection 1240584 - Astellas Pharma Inc. - 2024-04-18](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/2e3de0e1-9d1f-475a-85f3-e04a7c7755fb) — classification: No Action Indicated (NAI), source: FDA, date: April 18, 2024
- [483 - Astellas Pharma Inc. - 2019-10-07](https://www.keypedia.com/records/483/astellas-pharma-inc/23a6db75-8d9f-4df4-bf36-d0980ceca90d) — source: FDA, date: October 7, 2019
- [FDA Inspection 1095974 - Astellas Pharma Inc. - 2019-05-31](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/e871b725-33ca-4a2e-b543-a8afd7d76a52) — classification: No Action Indicated (NAI), source: FDA, date: May 31, 2019
- [FDA Inspection 995338 - Astellas Pharma Inc. - 2016-11-11](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/afba335b-459c-4410-8d03-ca5cc42652ae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2016
- [FDA Inspection 886636 - Astellas Pharma Inc. - 2014-06-25](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/8dd9e7ea-0320-4761-8e1a-772453b5b4d2) — classification: No Action Indicated (NAI), source: FDA, date: June 25, 2014
- [FDA Inspection 770005 - Astellas Pharma Inc. - 2012-02-10](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/2d4f2d93-b728-4d30-96ab-d1d8e3af4365) — classification: No Action Indicated (NAI), source: FDA, date: February 10, 2012
- [FDA Inspection 548515 - Astellas Pharma Inc. - 2008-10-31](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/e0982a5e-2e2c-4c69-8243-69a3864e812a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 31, 2008

## Related Companies

- [Fresenius Kabi Austria Gmbh](https://www.keypedia.com/companies/fresenius-kabi-austria-gmbh/f0cc0bbb-a42b-4b48-9334-0426fb359254)
- [Hovione FarmaCiencia SA](https://www.keypedia.com/companies/hovione-farmaciencia-sa/e55a2dd8-7c1c-493d-8511-9761732d75ec)
- [Siegfried USA, LLC](https://www.keypedia.com/companies/siegfried-usa-llc/0e21650d-f620-4e29-a62d-aa4ecd79cef2)
- [Novartis d.o.o.](https://www.keypedia.com/companies/novartis-doo/55471e35-a203-4edf-a4b9-fe1ad0bb16fd)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/86ee0564-73c3-4575-acbc-56fb8e87627c)
- [Sun Pharmaceutical Industries Limited](https://www.keypedia.com/companies/sun-pharmaceutical-industries-limited/51c5d6b8-303e-4e32-bbef-eaca05e879ef)
- [Vistin Pharma AS avd Kragero Fikkjebakke](https://www.keypedia.com/companies/vistin-pharma-as-avd-kragero-fikkjebakke/6acc0a66-9192-481c-a1bf-4d4d0cbf68e7)
- [Asymchem Life Science (Tianjin) Co., Ltd.](https://www.keypedia.com/companies/asymchem-life-science-tianjin-co-ltd/ccb993d1-42a4-40fe-9c05-bf590f287eeb)
- [Sparhawk Laboratories Inc](https://www.keypedia.com/companies/sparhawk-laboratories-inc/0edcf26d-ffdf-460f-b9fd-264b336000d5)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/404ebab5-56a6-486d-bb01-be43a9478fad)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)
- [Jacek Cieslak](https://www.keypedia.com/people/jacek-cieslak/81b12add-49f1-4dfd-bcb1-60bc5b212b68)